A two-in one covid and flu jab is being tested, vaccination developer Moderna has announced. Scientists have developed an alternative to the current separate inoculations with the trial already under way.
And this could be expanded from a two-in-one jab to a three-in-one vaccination covering not only coronavirus and influenza but also lung infection RSV. This trial is due to be launched within the next two months and if successful it could be available as early as winter 2024.
Dr Paul Burton, Moderna’s chief medical officer, was speaking as he called for action over the current vaccination policy. He said people could find themselves “under-protected and under-vaccinated” if the Government maintained its rules which severely limit who can have the fourth jab. And he called for younger adults and children to be eligible for booster jabs in the autumn
